AL-LAD

AL-LAD
Clinical data
Other namesALLAD; AllylLAD; Allyl-LAD; ALLYLAD; AllyLAD; ALLY-LAD; 6-Allyl-6-nor-LSD; 6-Allyl-6-nor-N,N-diethyllysergamide; 9,10-Didehydro-6-allyl-N,N-diethylergoline-8β-carboxamide
Routes of
administration
Oral
Drug classNon-selective serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Legal status
Legal status
  • AU: Unscheduled
  • CA: Unscheduled.
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
  • US: Unscheduled, could be illegal if is sold for human consumption under the Federal Analogue Act.
  • Illegal in Denmark, Sweden, Switzerland and France, could be illegal in many countries if is sold for human consumption or under the several analogue acts
Pharmacokinetic data
Onset of action15–20 minutes or hours
Duration of action6–8 hours
Identifiers
  • (6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H27N3O
Molar mass349.478 g·mol−1
3D model (JSmol)
  • [H][C@@]12Cc3c[nH]c4cccc(C1=C[C@@H](C(=O)N(CC)CC)CN2CC=C)c34
  • InChI=1S/C22H27N3O/c1-4-10-25-14-16(22(26)24(5-2)6-3)11-18-17-8-7-9-19-21(17)15(13-23-19)12-20(18)25/h4,7-9,11,13,16,20,23H,1,5-6,10,12,14H2,2-3H3/t16-,20-/m1/s1 checkY
  • Key:JCQLEPDZFXGHHQ-OXQOHEQNSA-N checkY
  (verify)

AL-LAD, or ALLAD, also known as ALLY-LAD or as 6-allyl-6-nor-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is taken orally.

The drug interacts with serotonin and dopamine receptors and is known to act as an agonist of the serotonin 5-HT2A receptor similarly to LSD. AL-LAD produces psychedelic-like effects in animals. It is closely structurally related to LSD and to other psychedelic lysergamides such as ETH-LAD and PRO-LAD.

AL-LAD was first described in the scientific literature by 1976. Subsequently, it was described by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines i Have Known And Loved). AL-LAD was encountered as a novel designer recreational drug by 2015. The related drugs 1P-AL-LAD, 1cP-AL-LAD, and 1T-AL-LAD are thought to function as prodrugs of AL-LAD and have also been encountered as designer drugs in the 2020s.